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PRECIS Using an indication-only approach to establishing intravenous access in patients 




 Although placement of an intravenous (IV) cannula for women in labor is a common 
practice there is limited data to support this as routine practice. 
 Indication-only IV cannulation for women in spontaneous labor resulted in 28% of 
patients never requiring IV access during their admission. 
 IV access established during labor and birth prior to a diagnosis of postpartum 
hemorrhage or excessive bleeding is not associated with decreased blood loss or 
higher postpartum hematocrit and hemoglobin levels when compared with IV 
placement at the time of the postpartum hemorrhage.  
 
ABSTRACT    
Introduction: In the United States, most women presenting in spontaneous labor undergo 
intravenous cannulation on admission to hospital labor and delivery units. There is limited 
evidence for this routine practice in pregnant women at low risk for adverse outcomes during 
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Methods: A retrospective, exploratory, descriptive study of an indication-only practice of 
intravenous (IV) cannulation on admission for women presenting in spontaneous labor and 
cared for by a nurse-midwife service was performed. Descriptive data included the timing of 
IV cannula placement (admission, during labor or postpartum period, or not at all), and 
indications for placement. Maternal outcomes of interest were estimated blood loss, 
postpartum hemorrhage rates and management; neonatal outcome was 5 minute Apgar 
scores.  
Results: Records for 1069 women cared for by nurse-midwives who presented in 
spontaneous labor and were were reviewed. In this cohort, 445 (41.6%) had IV access 
established on admission, 325 (30.4%) had an IV placed during labor or postpartum, and 299 
(28%) never had IV access during their hospital stay. For the 325 women with IV cannulas 
placed after admission, 25 (7.7%)  were placed urgently for excessive postpartum bleeding.  
Further analysis of the subset of women who had a postpartum hemorrhage after vaginal birth 
(defined as > 500 mL estimated blood loss) indicated that urgent IV cannulation was not 
associated with a lower mean postpartum hemoglobin or hematocrit, nor an increase in blood 
transfusion rate when compared to women who had an IV placed earlier in their labor course.  
Discussion: Indication-only IV cannulation for women experiencing an uncomplicated labor 
and birth is a reasonable practice in settings where IV access can be established urgently if 
needed.  
Word count 281 
 
KEYWORDS  spontaneous labor, intravenous access, IV cannulation, saline-lock, 




Although the actual number of women who have an intravenous (IV) cannula placed 
during labor is unknown, 62% of women in the United States Listen to Mother’s survey 
reported receiving IV fluids during labor.
1
 For low-risk women admitted in spontaneous 
labor, routine hospital admission orders often include placement of an IV, irrespective of a 
clear need for intravenous access. Women considered low-risk are those who have an 
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priori risk factors for complications during labor or birth.
2
 It is unclear that routine placement 
of an IV in a low risk woman is beneficial or reduces risk for mother or fetus.  
Intravenous cannulation, often referred to as a “saline-lock” (flushed with 10 mL of 
normal saline to prevent occlusion)
3
 establishes IV access via a capped catheter. Because IV 
access has already been established, subsequent need for fluids and medications can be 
addressed more quickly in cases of emergent surgery, fetal distress, or maternal 
hemodynamic instability. The objective of this retrospective descriptive analysis is to explore 
outcomes in a nurse-midwifery practice where IV cannulation in low risk women presenting 
in active labor is done based on indication rather than as a routine practice.  
BACKGROUND 
Establishing intravenous access became routine during the mid 20
th
 century as part of 
managing labor and birth as a surgical procedure. This management also included sedation 
(twilight sleep), routine episiotomy, and forceps use.
4
 Women were instructed not to eat or 
drink to prevent risk of aspiration and consequently intravenous fluids were routinely 
administered.
5
 Since that time, many of these interventions are no longer common practice, 
yet routine IV cannulation continues to be standard practice in many hospital based labor and 
delivery units. The administration of IV fluids and restriction of oral nutrition and/or fluids is 
also common practice.
6
. While current postpartum hemorrhage (PPH) prevention guidelines 
do not include routine placement of IV cannula for access,
7,8,9 
 an additional rationale for 
routine IV cannulation is the ability to institute rapid fluid resuscitation during PPH as well as 
for ease of oxytocin and other medication administration if needed. Several studies have 





however, the benefit of these protocols for emergency care during 
childbirth has not been studied.  
Although establishing IV access may be viewed as a benign intervention, the 
procedure does induce a risk of infection, superficial phlebitis, or thrombus.
12
 Even with 
anesthetic use, IV placement is painful.
13
 Cost associated per each IV cannulation is 
estimated to be between $69 and $237.
14
 Whether an indication-based approach versus 
routinely establishing IV access during labor is associated with delay of treatment or an 
increase in the incidence of adverse effects is unknown. Therefore, the purpose of this study 
was to explore timing of IV placement and if an indication-only protocol for IV cannulation 
is associated with increased maternal blood loss or lower newborn Apgar scores. A 
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hospital and cared for by nurse-midwives was performed. The primary outcome was to 
describe the timing and indication for IV placement when an indication-only approach is 
used. Secondary outcomes included estimated blood loss, postpartum hemoglobin and 
hematocrit, and five minute Apgar scores.  
 
METHODS 
This was a retrospective descriptive analysis of maternity care outcomes from a large 
midwestern university hospital. Ongoing data collection had been occurring by the nurse-
midwifery service for quality improvement and to assess outcomes of care for the last 35 
years. The nurse-midwifery service is a collaborative practice model with independent 
midwifery care during the antepartum, intrapartum and postpartum period unless medical 
complications necessitate physician consultant involvement. This nurse-midwifery service 
cares for approximately 700 women giving birth each year, with an overall 22% induction 
rate and 17% cesarean rate.
15
 
From January 1, 2015 to December 31, 2016, data were reviewed from women 
admitted in spontaneous labor and receiving care with the nurse-midwifery service. Women 
included in the study presented in spontaneous labor, were established nurse-midwifery 
service patients, without medication-requiring gestional diabetes or hypertension, greater than 
34 weeks gestation with a singleton, vertex fetus, with reassuring fetal status at time of 
admission. Women presenting for induction of labor and women who presented in labor but 
were not a candidate for vaginal birth at time of admission (eg, breech presentation, placenta 
previa, Category III fetal heart rate pattern, evidence of placental abruption) were excluded 
from this analysis.  
The nurse-midwifery service recommends IV cannulation at time of admission in 
labor only if there is an indication, for example, history of PPH or prior cesarean birth. 
Commonly, during labor, birth, and postpartum, IV access is recommended for concerning 
changes in maternal and/or fetal status. Some women decline placement of an IV cannula 
despite this recommendation, for example when a woman has a previous cesarean birth or has 
excessive postpartum bleeding. In these situations, ongoing discussion, shared decision 
making, and risk assessment continues while respecting individual autonomy and choice. 
Woman presenting for care in the hospital labor and birth unit have a complete blood count 
and type and screen collected routinely on admission. A repeat complete blood count is 
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During the period of data collection at this facility, postpartum blood loss was visually 
estimated rather than quantified. An estimated blood loss of greater than 500 millliters (mL) 
was defined as a PPH for vaginal births. During antenatal care, active management of third 
stage labor with 10 Units of oxytocin given intramuscularly for all women immediately post 
vaginal delivery is discussed. If a woman declines active management of the third stage, it is 
documented in the record and in the quality improvement database.  
For this study, Institutional Review Board approval was obtained with a waiver of 
informed consent. Then, a review of the quality improvement data base was completed to 
identify low risk women admitted in spontaneous labor, singleton pregnancy, vertex fetus and 
greater than 34 weeks. Next, a focused chart review in the electronic health record was 
completed to document the timing and indication of IV placement. Descriptive data obtained 
included age, number of pregnancies, number of births, body mass index, gestational age at 
onset of labor, mode of birth, and 5-minute Apgar score. Admission complete blood counts 
and subsequent blood counts were collected for women who experienced PPH following 
vaginal birth. Estimated blood loss was recorded.  
Timing of IV placement was divided into three groups: 1) IV placement at the time of 
admission, 2) IV placement later in labor or postpartum, and 3) no IV placement during the 
intrapartum and postpartum period. For all IV placements, the indication was documented. 
Indications for urgent IV placement were concerning immediate maternal or fetal status 
changes, including category III fetal heart rate pattern, active maternal bleeding, severe 
hypertension, signs or symptoms of hemodynamic instability including acute changes in 
maternal pulse, blood pressure, oxygen saturation and syncope. The electronic medical record 
was reviewed by two of the three authors to confirm the information. For all of these 
indications. 
Additionally, for all patients with a documented immediate PPH of 500mL or more 
after vaginal birth, admission and postpartum hemoglobin and hematocrit, use of uterotonics, 
blood transfusion, and management of the post partum hemorrhage was collected for review.  
Data was analyzed in SPSS version 24 with frequencies, mean, chi-square, t-test and 
ANOVA.  
RESULTS 
During the time period between January 2015 to December 2016, 1069 women 
presented in spontaneous labor at or after 34 weeks gestation with a singleton, vertex fetus. 
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multiparous (62.8%) and with a BMI less than 30 kg/m
2
 (85.1%). Mean age was 30.3 years 
and mean gestational age at the onset of laborwas 40 weeks.  Less than half (41.9%) received 
neuraxial analgesia. Fetal monitoring with exclusive intermittent auscultation was utilized for 
297 (27.8%) of the women.The cesarean birth rate for this cohort of low risk women was 
7.5%.  Five newborns were assigned an Apgar score of less than seven at five minutes of life 
(0.5%).  
Of the 1069 women included in this analysis, 445 (41.6%) had IV cannulation at admission, 
325 (30.4%) had IV cannulation later (either during labor or postpartum), and 299 (28%) 
never had IV access established. There were anticipated differences in labor management 
practices associated with required IV placement such as need for group B streptococcus 
(GBS) prophylaxis or placement of neuraxial analgesia Notably,women monitored only with 
intermittant auscultation were much less likely to have an IV placed  (161 of 297 [54.2%,] 
compared with women with who had continuous electronic fetal monitoring during their 
labor (138 of 772 [17%]) .  
For postpartum maternal outcomes, analysis was conducted using the subset of 
women who had a vaginal birth (n = 989). Active management of the third stage of labor 
(AMTSL) with 10 units of oxytocin administered intramuscularly immediately following the 
birth is recommended for all patients at this institution regardless of IV access. However, 
28.6% of women in the overall sample declined AMTSL and a significantly higher number of 
women who never had IV access declined AMTSL when compared to women who had an IV 
placed on admission or an IV placed in labor (45.2% vs 22.8% and 18.8% respectviely, 
P<.001). Postpartum hemorrhage with estimated blood loss greater than or equal to 500mL 
occurred in 108 women (11.3%) overall.  
The timing and indications for intravenous placement are presented in Table 2. The 
most common indications for IV placement on admission were: GBS colonization requiring 
antibiotic prophylaxis, trial of labor after cesarean and presence of risk factors for PPH 
(which were defined as history of PPH, blood clotting disorder, or parity > 4). For women 
who received IV cannulation during the labor process, the most common reasons were 
maternal request for neuraxial analgesia or intravenous pain medication. There were no 
urgent IV placements during labor.  
During the postpartum period, 36 women had intravenous cannulas placed and of those, 27 
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all IV placements. Indications for urgent placement were excessive postpartum bleeding (25 
women) and syncope unrelated to PPH (2 women).  
Of  the 108 women with a PPH after vaginal birth, 70 women already had an IV 
placed and 38 women did not have an IV at the time the PPH was identified. Most women 
with a PPH had an estimated blood loss of 500 mL or more but less than 1000 mL, however 
32 (29.6%) had an estimated blood loss greater than or equal to 1000 mL. (Table 3) Of thse 
38 women who did not have an IV, 15 declined placement of an IV cannula despite 
recommendation for placement secondary to excessive bleeding although only one woman 
with an estimated blood loss of 1000 mL or more declined IV placement.  
The outcomes of the subgroup of women experiencing PPH after vaginal delivery 
were evaluated. For this cohort of women,  the mean hemoglobin was 12.2g/dL and 
hematocrit was 35.7% on admission. Following birth, the mean hemoglobin was 9.9 g/dL and 
hematocrit was 29.1% for this cohort. There were no significant differences in the admission 
to postpartum change in hemoglobin and hematocrit values between women with an IV 
placed earlier in the labor course, placed urgently, and women who declined IV placement.   
Misoprostol administered per rectum was the most common uterotonic used to treat 
PPH (66.7%) followed by intramuscular methergine (22.2%). Intravenous oxytocin was not 
used as a single agent to treat PPH, however in some cases it was used secondarily if the 
patient had IV oxytocin infusing during labor (18 of 108 women, [18.5%]). Patients with 
urgent IV placement were more likely to receive misoprostol when compared to those who 
had an IV already in place (91.3% versus 61.4% respectively; P=.015). Of the 108 women 
with PPH, 13 were transferred to an operating room, with 4 women ultimately receiving a 
dilation and curettage procedure to evacuate the uterus. Seven women required a transfusion 
with 2 units of blood (6.5% of all women with a PPH), 6 of whom had IV placement on 
admission and one who had urgent IV placement for PPH.  There were not significant 
differences in the need for transfusion, transfer to the operating room, or need for dilitation 
and curettage when women who already had an IV placed were compared to women who had 
an urgent placement. None of the 15 women who declined urgent IV placement required 
blood transfusion, transfer to the operating room, or dilitation and curettage. 
Six women declined both active management of third stage and IV cannulation at the 
time of PPH. In this cohort, one woman received no uteronics, one was given misoprostol per 
rectum only, 2 had IM oxytocin only and 2 had both misoprostol and IM oxytocin. All 6 








In this retrospective, descriptive study, we explored the outcome of the policy to 
establish IV access based on specific indications for women who were low-risk for labor 
complications at the onset of labor, admitted in spontaneous labor at a gestational age of 34 
weeks or greater. Less than half of the women (41.6%) had an IV cannula placed on 
admission and 28% never required IV access. However, for women who had a PPH, there 
was no difference in postpartum hemoglobin or hematocrit values regardless of whether IV 
access was ever placed. This would suggest that for women who are low risk presenting in 
spontaneous labor, IV access on admission may not be mandatory, particularly in high 
resourced facilities.  
To our knowledge, there are no published studies of the impact of routine IV 
cannulation compared to indication-only IV access for women who are low-risk and in 
spontaneous labor. A review of the literature regarding outcomes of establishing IV access in 
emergency departments, indicates that many IV insertions were never utilized which led to 
preventable complications  and financial burden from unnecessary IV cannulation.
16
 The 
authors concluded that there is a culture in emergency departments of misperceived risk and 
lack of confidence that results in routine IV placements. The same may be applicable to the 
culture in maternity care units where healthy, laboring women have an IV placed as a routine 
practice. 
The majority of women in the United States give birth in a hospital,
17
 and while no 
source could be found for actual numbers, establishing IV access is often part of the hospital 
admission process or protocol.  Results of this study indicate that a policy of establishing IV 
access when there is an indication instead of routinely for low risk spontaneously laboring 
woman may be a safe and reasonable practice. This practice would result in a cost and time 
savings, decrease patient discomfort, and facilitate mobility during labor and birth. Potential 
risk of venous complications would be avoided.  
This study, while the first to explore the outcomes of indication-only IV access in 
labor, is not without limitations. This was a retrospective, observational study utilizing a data 
collection tool used for quality improvement purposes with targeted medical chart review. 
Data on the number of attempts at IV cannulation was missing for many of the 27 urgent 
placements, preventing analysis of whether or not waiting for IV access results resulted in a 
more difficult placement under an urgent clinical situation. Although there was no significant 
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management between women who had an IV placed on admission or during labor and those 
who had an IV placed for PPH a difference in clinical symptoms such as syncope is not 
known.  Women included in the study were  predominately white, privately insured, healthy, 
and at low risk for complications, thus the results may not apply to women from other 
demographic groups. Finally, the setting for this study was in a high resourced, high volume 
hospital, therefore, results may not be generalizable to lower resourced or smaller settings.  
CONCLUSION 
Professional organizations have called for decreasing unnecessary intervention and 
respecting individual’s choices during childbirth.
18,19
 Respectful maternity care includes 
honoring laboring women’s choices for their birth, including avoiding interventions such as 
routine IV placement. While further study is needed, a policy of indication-only IV access 
during spontaneous labor is reasonable in a higher resourced setting, fiscally responsible, and 
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Table 1: Demographic, antenatal and labor characteristics of women admitted in 
spontaneous labor N=1069 







No IV placed  
Total N (%)  445 (41.6) 325 (30.4) 299 (28.0) 




30.6 (15-47) 29.3 (16-
42) 
30.7 (17-43) 
Insurance n (%)     
Private 835 (78.1) 348 (78.2) 244 (75.1) 243 (81.3) 
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None 12 (1.1) 3 (0.7) 5 (1.5) 4 (1.3) 
Race/Ethnicity n (%)     
White 873 (81.7) 356 (80.0) 264 (81.2)  253 (84.6)  
Black 106 (9.9) 51 (11.5) 31 (9.5)  24 (8.0) 
Other 90 (8.4) 38 (8.5) 30 (9.2) 22 (7.4) 
Parity n (%)     
Nulliparous women 398 (37.2) 147 (33.1) 164 (50.4) 87 (29.1) 
Multiparous women 671 (62.8) 298(66.9) 161 (49.6) 212 (70.9) 
GBS+ n (%)     
Yes 287 (26.8) 270 (60.7) 4 (1.2) 13 (4.3) 
No 736 (68.8) 157 (35.3) 309 (95.1) 270 (90.3) 
Unknown 46 (4.3) 18 (4.0) 12 (3.7) 16 (5.4) 
BMI n (%)     
≤ 29.9 kg/m
2 
908 (85.1) 372 (83.8) 270 (83.1) 266 (89.3) 
≥ 30.0 kg/m
2
 159 (14.9) 72 (16.2) 55 (16.9) 32 (10.7) 
History of prior 
cesarean birth n (%) 
    
Yes 107 (10.0) 66 (15.3) 26 (8.0) 13 (4.3) 
No  962 (90.0) 377 (84.7) 299 (92.0) 286 (95.7) 
EGA, Mean (Range), 
weeks 
40 (34-43) 40 (35-43) 40 (35-43) 40 (36-42) 
Neuraxial analgesia n 
(%) 
    
Yes 448 (41.9) 200 (44.9) 248 (76.3) 0 (0.0) 
No 621 (58.1) 245 (55.1) 77 (23.7) 299 (100.0) 
Fetal Monitoring n (%)     
Only IA 297 (27.8) 85 (19.1)  51 (17.2) 161 (53.8) 
cEFM 772 (72.2) 360 (80.9) 274(84.3) 138 (46.1) 
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Yes  80 (7.5) 49 (15.0) 31 (7) 0 (0.0) 
No  989 (92.5) 395 (85) 294 (93) 299 (100) 
5 minute Apgar <7 n 
(%) 
    
Yes  5 (0.5) 3 (0.6) 2 (0.6) 0 (0.0) 
No  1064 (99.5) 442 (99.4) 323 (99.4) 299 (100) 
AMTSL n (%)
a
     
Yes 675 (71.4) 304 (77.2) 211 (81.2) 160 (54.8) 
No 271 (28.6) 90 (22.8) 49 (18.8) 132 (45.2) 
PPH n (%)
b
     
Yes 108 (11.3) 37 (9.0) 56 (20.2) 15 (5.0) 
No 881 (88.7) 376  (91.0) 221 (78.8) 284 (95.0) 
Abbreviations: BMI, Body Mass Index; EGA, Estimated Gestational Age; GBS, Group Beta 
Strep; IA, intermittent auscultation; cEFM, continuous electronic fetal monitoring, AMTSL 
active management of third stage of labor: PPH postpartum hemorrhage 
a 
Total n = 946, 43 missing cases cesarean births are excluded 
b
Total n = 989 cesarean births are excluded 
 
Table 2: Timing and indication for placement of intravenous access n=770 
 Total 





n = 445 
n (%) 
 
IV placed later 
during labor or 
postpartum 
n = 325 
n (%) 
 
Indication on admission    
GBS positive  279 (36.2) 274 (61.6) 5 (1.5) 
TOLAC  41 (5.3) 40 (9.0) 1 (0.3) 
PPH risk  19 (2.4) 19 (4.3) 0 
No rationale documented 8 (1.0) 8 (1.8) 0  
Other indication
a
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Intrapartum indication    
Neuraxial analgesia 303 (39.3) 67 (15.0) 236 (72.6) 
Opioid pain relief 47 (6.1) 16 (3.6) 31 (9.5) 
Hydration 9 (1.0) 5 (1.1) 4 (1.2) 
Category II FHR  7 (0.9) 5 (1.1) 2 (0.6) 
Augmentation 6 (0.8) 1 (0.2) 5 (1.5) 
Preeclampsia 5 (0.6) 3 (0.7) 2 (0.6) 
Unstable fetal presentation 2 (0.2) 1 (0.2) 1 (0.3) 
Cesarean birth
b
 1 (0.1) 0  1 (0.3) 
Fever 1 (0.1) 0 1 (0.3) 
Postpartum indication    
Excessive bleeding 25 (3.2) n/a  25 (7.7)
c
 
Laceration repair requiring 
neuraxial analgesia 
5 (0.6) n/a  5 (1.5) 
Retained placenta removal 2 (0.2) n/a  2 (0.6) 
Syncope 2 (0.2) n/a  2 (0.6)
 c
 
Dizziness 1 (0.1) n/a  1 (0.3) 
Non specific chest pressure 1 (0.1) n/a  1 (0.3) 
Abbreviations: FHR, Fetal heart rate; GBS, Group b streptococcus; PPH, postpartum 
hemorrhage TOLAC, Trial of labor after cesarean; n/a, not applicable 
a
 laboring woman’s request (1), nausea management (1), IV steroid administration (1), 
maternal tachycardia (1), maternal bradycardia (1), known fetal anomalies (2)  
b
 After experiencing an arrest of descent during labor, an IV was placed at time of decision to 
proceed with cesarean birth 
c
 urgent IV placement 
 
Table 3: Women with postpartum hemorrhage after vaginal birth n=108 
 Total 














Estimated Blood Loss n 
(%) 
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16 
500-999 mL 76 (70.4) 50 (71.4)  12 (52.2) 14 (93.3)  
≥1000 mL 32 (29.6)) 20 (28.6) 11 (47.8) 1 (6.7)  


























































Interventions n (%)   
AMTSL 78 (72.2) 57 (81.4) 12 (52.2) 9 (60) .01 
Misoprostol 72 (66.7) 43 (61.4) 21 (91.3) 8 (53.3) .02 
Methergine 24(22.2) 15 (21.4) 9 (39.1) 0 (0.0) .02 
Oxytocin IV 20 (18.5) 14 (20) 6 (26.1) 0 (0) .11 
 Oxytocin IM 18 (16.7) 8 (11.4) 6 (26.1) 4 (26.7) .14 
Transfer to operating room 13 (12) 10 (14.3) 3 (13) 0 (0.0) .30 
Transfusion 7 (6.5) 6 (8.6) 1 (4.3) 0 (0.0) .42 
Dillitation & curretage 4 (3.7) 2 (2.9) 2 (8.7) 0 (0.0) .31 
Abbreviations: AMTSL, active management third stage labor; Hct, hematocrit; Hgb, 
hemoglobin; IM, intramuscular; IV, intravenous 
a
 n = 94 due to missing data 
b
 n = 78 due to missing data  
 
 
